🔓 Unlock the full profile of Brian Kim (Icahn School Of Medicine At Mount Sinai), including verified contact details, financial insights, and professional associations.
See Brian Kim Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: bri*****@ica******.com
Mobile: 98763*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Brian Kim serves as a Co-Founder at the Icahn School of Medicine at Mount Sinai, which is known for its innovative medical education and research initiatives.
- In 2022, Brian Kim co-founded KliRNA Biotech, focusing on advancements in biotechnology and its applications in medicine.
- Currently co-founding Alys Pharmaceuticals as of October 2023, Brian Kim aims to drive drug discovery and development efforts in the pharmaceutical industry.
- Previously held the position of Associate Professor of Medicine, Anesthesiology, and Pathology and Immunology at Washington University School of Medicine, contributing to education and medical research in these fields.
- Co-directed the Center for the Study of Itch at Washington University, aiming to explore the biological mechanisms and treatment options for chronic itching disorders.
- Worked as Founder and Chief Scientific Officer at Nuogen Pharma, where efforts were directed toward drug development and innovation in biotechnology.
- Served in various clinical and research roles over the years, including Clinical Instructor of Dermatology and Dermatology Resident, building expertise in dermatological sciences.
- Completed postdoctoral training at the Perelman School of Medicine, solidifying a foundation in research and enhancing capabilities in medical sciences.
- Worked as a research fellow at the National Institutes of Health, contributing to significant biomedical research initiatives.